140 related articles for article (PubMed ID: 2416331)
1. Tofisopam and midazolam: differences in clinical effects and in changes of CSF monoamine metabolites.
Hovi-Viander M; Kanto J; Scheinin H; Scheinin M
Br J Clin Pharmacol; 1985 Nov; 20(5):492-6. PubMed ID: 2416331
[TBL] [Abstract][Full Text] [Related]
2. [Concentrations of monoamines and monoamine metabolites in cerebrospinal fluid determined by high-performance liquid chromatography with electrochemical detection].
Yoshino K
No To Shinkei; 1982 Nov; 34(11):1099-106. PubMed ID: 6186264
[TBL] [Abstract][Full Text] [Related]
3. CSF-amine metabolites in depression, dementia and in controls.
Gjerris A; Werdelin L; Gjerris F; Sørensen PS; Rafaelsen OJ; Alling C
Acta Psychiatr Scand; 1987 Jun; 75(6):619-28. PubMed ID: 2441573
[TBL] [Abstract][Full Text] [Related]
4. Monoamine metabolites in normal human cerebrospinal fluid and in degenerative diseases of the central nervous system.
González-Quevedo A; García JC; Fernández R; Fernández Cartaya L
Bol Estud Med Biol; 1993; 41(1-4):13-9. PubMed ID: 7521168
[TBL] [Abstract][Full Text] [Related]
5. Biogenic amine metabolites in human CSF after hypoxia due to cardiac arrest.
Odink J; Kärkelä J; Thissen JT; Marnela KM
Acta Neurol Scand; 1989 Jul; 80(1):6-11. PubMed ID: 2476907
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid monoamine metabolites and neuropeptides in patients with panic disorder.
Lepola U; Jolkkonen J; Pitkänen A; Riekkinen P; Rimón R
Ann Med; 1990; 22(4):237-9. PubMed ID: 1701091
[TBL] [Abstract][Full Text] [Related]
7. Phenylethylamine and monoamine metabolites in CSF of schizophrenics: effects of neuroleptic treatment.
Beckmann H; Waldmeier P; Lauber J; Gattaz WF
J Neural Transm; 1983; 57(1-2):103-10. PubMed ID: 6194254
[TBL] [Abstract][Full Text] [Related]
8. Monoamine metabolites in human cerebrospinal fluid: indicators of neuronal activity?
Scheinin M
Med Biol; 1985; 63(1):1-17. PubMed ID: 2582215
[TBL] [Abstract][Full Text] [Related]
9. CSF monoamine metabolism in patients with tardive dyskinesia: effect of oxypertine and hydroxyzine pamoate.
Akiyama K; Nagao T; Yamamoto M; Fujimoto A; Ebara T; Sato M; Otsuki S
Folia Psychiatr Neurol Jpn; 1983; 37(2):129-35. PubMed ID: 6200411
[TBL] [Abstract][Full Text] [Related]
10. Monoamine metabolites in ventricular CSF of children with posterior fossa tumors: correlation with tumor histology and cognitive functioning.
Varela M; Alexiou GA; Liakopoulou M; Papakonstantinou E; Pitsouni D; Alevizopoulos GA
J Neurosurg Pediatr; 2014 Apr; 13(4):375-9. PubMed ID: 24559277
[TBL] [Abstract][Full Text] [Related]
11. CSF concentration gradients of monoamine metabolites in patients with hydrocephalus.
Malm J; Kristensen B; Ekstedt J; Wester P
J Neurol Neurosurg Psychiatry; 1994 Sep; 57(9):1026-33. PubMed ID: 7522267
[TBL] [Abstract][Full Text] [Related]
12. No major influence of regular tobacco smoking on cerebrospinal fluid monoamine metabolite concentrations in patients with psychotic disorder and healthy individuals.
Hjärpe J; Söderman E; Andreou D; Sedvall GC; Agartz I; Jönsson EG
Psychiatry Res; 2018 May; 263():30-34. PubMed ID: 29482043
[TBL] [Abstract][Full Text] [Related]
13. Spinal reflexes and the concentrations of 5-HIAA, MHPG, and HVA in lumbar cereborspinal fluid after spinal lesions in man.
Ashby P; Verrier M; Warsh JJ; Price KS
J Neurol Neurosurg Psychiatry; 1976 Dec; 39(12):1191-200. PubMed ID: 1011029
[TBL] [Abstract][Full Text] [Related]
14. Dose-dependent effects of deprenyl on CSF monoamine metabolites in patients with Alzheimer's disease.
Sunderland T; Tariot PN; Cohen RM; Newhouse PA; Mellow AM; Mueller EA; Murphy DL
Psychopharmacology (Berl); 1987; 91(3):293-6. PubMed ID: 2436247
[TBL] [Abstract][Full Text] [Related]
15. Monoamine metabolite levels in rat CSF: kinetic studies.
Scheinin H; Scheinin M
Pharmacol Toxicol; 1987 Sep; 61(3):167-71. PubMed ID: 2446306
[TBL] [Abstract][Full Text] [Related]
16. Tryptophan and biogenic amine metabolites in post-mortem human cisternal fluid: effects of post-mortem interval and agonal time.
Kärkelä J; Scheinin M
J Neurol Sci; 1992 Feb; 107(2):239-45. PubMed ID: 1373441
[TBL] [Abstract][Full Text] [Related]
17. [The changes of monoamine metabolites in CSF of patients with cerebral stroke].
Tang HZ
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1991 Jun; 24(3):130-2, 186. PubMed ID: 1716195
[TBL] [Abstract][Full Text] [Related]
18. Monoamine metabolites in cerebrospinal fluid and serotonin uptake inhibition during treatment with chlorimipramine.
Asberg M; Ringberger VA; Sjöqvist F; Thorén P; Träskman L; Tuck JR
Clin Pharmacol Ther; 1977 Feb; 21(2):201-7. PubMed ID: 13959
[TBL] [Abstract][Full Text] [Related]
19. Concentrations of monoamine metabolites in the cerebrospinal fluid of twins and unrelated individuals--a genetic study.
Oxenstierna G; Edman G; Iselius L; Oreland L; Ross SB; Sedvall G
J Psychiatr Res; 1986; 20(1):19-29. PubMed ID: 2423688
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid levels of monoamine metabolites. A preliminary study of their relation to menstrual cycle phase, sex steroids, and pituitary hormones in healthy women and in women with premenstrual syndrome.
Eriksson E; Alling C; Andersch B; Andersson K; Berggren U
Neuropsychopharmacology; 1994 Nov; 11(3):201-13. PubMed ID: 7532413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
